Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9 –12 years) and adolescents

ConclusionThe generic SOF/LED fixed-dose combination is safe and effective in children, 9 –12 years, and adolescents with vRVR rate of 96%, 100% EOT response and SVR12.
Source: Hepatology International - Category: Infectious Diseases Source Type: research